Evidence map›Paper›PMID 31437249›Full record

ArticlePLoS pathogens2019

Dietary zinc and the control of Streptococcus pneumoniae infection.

Bart A Eijkelkamp, Jacqueline R Morey, Stephanie L Neville, Aimee Tan, Victoria G Pederick, Nerida Cole, Prashina P Singh, Cheryl-Lynn Y Ong, Raquel Gonzalez de Vega, David Clases and 11 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. mSphere · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. CFTR is required for zinc-mediated antibacterial defense in human macrophages.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Hfe Permease andACS infectious diseases · 2024
    Article
  15. Article
  16. TheMicrobiology spectrum · 2023
    Article
  17. Review
  18. Article
  19. Zinc acquisition and its contribution toFrontiers in cellular and infection microbiology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Bart A EijkelkampResearch Centre for Infectious Diseases, Department of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.ORCID 0000-0003-0179-8977
Jacqueline R MoreyDepartment of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
Stephanie L NevilleDepartment of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.ORCID 0000-0002-7298-9335
Aimee TanDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-7257-1051
Victoria G PederickDepartment of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.ORCID 0000-0001-9830-1060
Nerida ColeThe Atomic Medicine Initiative, University of Technology, Broadway, Sydney, New South Wales, Australia.ORCID 0000-0002-9866-4694
Prashina P SinghThe Atomic Medicine Initiative, University of Technology, Broadway, Sydney, New South Wales, Australia.
Cheryl-Lynn Y OngAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
Raquel Gonzalez de VegaThe Atomic Medicine Initiative, University of Technology, Broadway, Sydney, New South Wales, Australia.ORCID 0000-0002-9806-9633
David ClasesThe Atomic Medicine Initiative, University of Technology, Broadway, Sydney, New South Wales, Australia.
Bliss A CunninghamDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-4654-1972
Catherine E HughesResearch Centre for Infectious Diseases, Department of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.ORCID 0000-0002-2152-0238
Iain ComerfordDepartment of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
Erin B BrazelResearch Centre for Infectious Diseases, Department of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.ORCID 0000-0001-6632-687X
Jonathan J WhittallDepartment of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
Charles D PlumptreResearch Centre for Infectious Diseases, Department of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
Shaun R McCollDepartment of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
James C PatonResearch Centre for Infectious Diseases, Department of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
Alastair G McEwanAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-2419-1003
Philip A DobleThe Atomic Medicine Initiative, University of Technology, Broadway, Sydney, New South Wales, Australia.ORCID 0000-0002-8472-1301
Christopher A McDevittDepartment of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.ORCID 0000-0003-1596-4841
The University of Adelaide · AUUniversity of Technology Sydney · AUThe University of Melbourne · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human zinc deficiency increases susceptibility to bacterial infection. Although zinc supplementation therapies can reduce the impact of disease, the molecular basis for protection remains unclear. Streptococcus pneumoniae is a major cause of bacterial pneumonia, which is prevalent in regions of zinc deficiency. We report that dietary zinc levels dictate the outcome of S. pneumoniae infection in a murine model. Dietary zinc restriction impacts murine tissue zinc levels with distribution post-infection altered, and S. pneumoniae virulence and infection enhanced. Although the activation and infiltration of murine phagocytic cells was not affected by zinc restriction, their efficacy of bacterial control was compromised. S. pneumoniae was shown to be highly sensitive to zinc intoxication, with this process impaired in zinc restricted mice and isolated phagocytic cells. Collectively, these data show how dietary zinc deficiency increases sensitivity to S. pneumoniae infection while revealing a role for zinc as a component of host antimicrobial defences.

Indexed as

Dietary SupplementsDisease Models, AnimalAnimalsFemaleLung DiseasesMicePneumococcal InfectionsStreptococcus pneumoniaeVirulenceZincZinc

Identifiers

PMID31437249
PMCPMC6705770
OpenAlexW2969837772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.